NCT04932031View on ClinicalTrials.gov

Risk Prediction of Taxane Chemotherapy-Induced Peripheral Neuropathy

TerminatedOBSERVATIONAL
Enrollment

123

Participants

Timeline

Start Date

May 25, 2022

Primary Completion Date

November 1, 2023

Study Completion Date

November 1, 2023

Conditions
Breast CancerChemotherapy-induced Peripheral NeuropathyAging
Trial Locations (2)

27514

UNC Hospitals Adult Oncology Clinics, Chapel Hill

35294

University of Alabama at Birmingham, Birmingham

Sponsors

Lead Sponsor

Sapere Bio
All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

University of North Carolina

OTHER

collaborator

University of Alabama at Birmingham

OTHER

lead

Sapere Bio

INDUSTRY